KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Net Margin: 2020-2025

Historic Net Margin for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to -207.93%.

  • Ginkgo Bioworks Holdings' Net Margin fell 14459.00% to -207.93% in Q3 2025 from the same period last year, while for Sep 2025 it was -188.00%, marking a year-over-year increase of 11077.00%. This contributed to the annual value of -240.94% for FY2024, which is 11414.00% up from last year.
  • According to the latest figures from Q3 2025, Ginkgo Bioworks Holdings' Net Margin is -207.93%, which was down 71.05% from -121.56% recorded in Q2 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Net Margin peaked at -63.34% during Q3 2024, and registered a low of -1,080.85% during Q4 2021.
  • Over the past 3 years, Ginkgo Bioworks Holdings' median Net Margin value was -245.25% (recorded in 2024), while the average stood at -297.69%.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Net Margin slumped by 93,611bps in 2021, and later surged by 90,475bps in 2022.
  • Ginkgo Bioworks Holdings' Net Margin (Quarterly) stood at -1,080.85% in 2021, then surged by 90,475bps to -176.10% in 2022, then plummeted by 43,301bps to -609.10% in 2023, then spiked by 36,386bps to -245.25% in 2024, then plummeted by 14,459bps to -207.93% in 2025.
  • Its Net Margin was -207.93% in Q3 2025, compared to -121.56% in Q2 2025 and -188.25% in Q1 2025.